By contrast, hypermethylated CpGs were enriched for genes linked to neurological and hematological conditions (e.g., restless legs syndrome, hemihypertrophy), cell cycle regulation (aurora B signaling, stathmin family), and cancer‐related pathways (acute promyelocytic leukemia, Huntington disease). Here, STMN1 is linked to Hemihypertrophy.